TTA-P2 is a potent and selective blocker of T-type calcium channels in rat sensory neurons and a novel antinociceptive agent
- PMID: 21821734
- PMCID: PMC3198916
- DOI: 10.1124/mol.111.073205
TTA-P2 is a potent and selective blocker of T-type calcium channels in rat sensory neurons and a novel antinociceptive agent
Abstract
Several agents that are preferential T-type calcium (T-channel) blockers have shown promise as being effective in alleviating acute and chronic pain, suggesting an urgent need to identify even more selective and potent T-channel antagonists. We used small, acutely dissociated dorsal root ganglion (DRG) cells of adult rats to study the in vitro effects of 3,5-dichloro-N-[1-(2,2-dimethyl-tetrahydro-pyran-4-ylmethyl)-4-fluoro-piperidin-4-ylmethyl]-benzamide (TTA-P2), a derivative of 4-aminomethyl-4-fluoropiperdine, on T currents, as well as other currents known to modulate pain transmission. We found that TTA-P2 potently and reversibly blocked DRG T currents with an IC(50) of 100 nM and stabilized channel in the inactive state, whereas high-voltage-activated calcium and sodium currents were 100- to 1000-fold less sensitive to channel blocking effects. In in vivo studies, we found that intraperitoneal injections of 5 or 7.5 mg/kg TTA-P2 reduced pain responses in mice in phases 1 and 2 of the formalin test. Furthermore, TTA-P2, at 10 mg/kg i.p., selectively and completely reversed thermal hyperalgesia in diabetic rats treated with streptozocin but had no effect on the nociceptive response of healthy animals. The antihyperalgesic effects of TTA-P2 in diabetic rats were completely abolished by administration of oligonucleotide antisense for Ca(V)3.2 isoform of T channels. Thus, TTA-P2 is not only the most potent and selective blocker of T channels in sensory neurons yet described, but it also demonstrates the potential for the pharmacological effectiveness of this approach in addressing altered nociceptive responses in animal models of both inflammatory and neuropathic pain.
Figures
![Fig. 1.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3198916/bin/zmo0111164560001.gif)
![Fig. 2.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3198916/bin/zmo0111164560002.gif)
![Fig. 3.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3198916/bin/zmo0111164560003.gif)
![Fig. 4.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3198916/bin/zmo0111164560004.gif)
![Fig. 5.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3198916/bin/zmo0111164560005.gif)
![Fig. 6.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3198916/bin/zmo0111164560006.gif)
![Fig. 7.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3198916/bin/zmo0111164560007.gif)
Similar articles
-
Selective T-type calcium channel block in thalamic neurons reveals channel redundancy and physiological impact of I(T)window.J Neurosci. 2010 Jan 6;30(1):99-109. doi: 10.1523/JNEUROSCI.4305-09.2010. J Neurosci. 2010. PMID: 20053892 Free PMC article.
-
Inhibition of CaV3.2 T-type calcium channels in peripheral sensory neurons contributes to analgesic properties of epipregnanolone.Psychopharmacology (Berl). 2014 Sep;231(17):3503-3515. doi: 10.1007/s00213-014-3588-0. Epub 2014 May 7. Psychopharmacology (Berl). 2014. PMID: 24800894 Free PMC article.
-
In vitro characterization of T-type calcium channel antagonist TTA-A2 and in vivo effects on arousal in mice.J Pharmacol Exp Ther. 2010 Nov;335(2):409-17. doi: 10.1124/jpet.110.171058. Epub 2010 Aug 3. J Pharmacol Exp Ther. 2010. PMID: 20682849
-
Targeting of CaV3.2 T-type calcium channels in peripheral sensory neurons for the treatment of painful diabetic neuropathy.Pflugers Arch. 2014 Apr;466(4):701-6. doi: 10.1007/s00424-014-1452-z. Epub 2014 Jan 31. Pflugers Arch. 2014. PMID: 24482063 Review.
-
T-type calcium channels in chronic pain: mouse models and specific blockers.Pflugers Arch. 2014 Apr;466(4):707-17. doi: 10.1007/s00424-014-1484-4. Epub 2014 Mar 4. Pflugers Arch. 2014. PMID: 24590509 Review.
Cited by
-
Ultrasound-mediated spatial and temporal control of engineered cells in vivo.Nat Commun. 2024 Aug 27;15(1):7369. doi: 10.1038/s41467-024-51620-2. Nat Commun. 2024. PMID: 39191796
-
T- and L-Type Calcium Channels Maintain Calcium Oscillations in the Murine Zona Glomerulosa.Hypertension. 2024 Apr;81(4):811-822. doi: 10.1161/HYPERTENSIONAHA.123.21798. Epub 2024 Feb 16. Hypertension. 2024. PMID: 38507511 Free PMC article.
-
Melanopsin activates divergent phototransduction pathways in intrinsically photosensitive retinal ganglion cell subtypes.Elife. 2023 Nov 8;12:e80749. doi: 10.7554/eLife.80749. Elife. 2023. PMID: 37937828 Free PMC article.
-
Readiness of nociceptor cell bodies to generate spontaneous activity results from background activity of diverse ion channels and high input resistance.Pain. 2024 Apr 1;165(4):893-907. doi: 10.1097/j.pain.0000000000003091. Epub 2023 Oct 20. Pain. 2024. PMID: 37862056
-
Neuropathic pain; what we know and what we should do about it.Front Pain Res (Lausanne). 2023 Sep 22;4:1220034. doi: 10.3389/fpain.2023.1220034. eCollection 2023. Front Pain Res (Lausanne). 2023. PMID: 37810432 Free PMC article. Review.
References
-
- Aley KO, Levine JD. (2001) Rapid onset pain induced by intravenous streptozotocin in the rat. J Pain 2:146–150 - PubMed
-
- Choi S, Na HS, Kim J, Lee J, Lee S, Kim D, Park J, Chen CC, Campbell KP, Shin HS. (2007) Attenuated pain responses in mice lacking Ca(V)3.2 T-type channels. Genes Brain Behav 6:425–431 - PubMed
-
- Chuang RS, Jaffe H, Cribbs L, Perez-Reyes E, Swartz KJ. (1998) Inhibition of T-type voltage-gated calcium channels by a new scorpion toxin. Nat Neurosci 1:668–674 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases